Perbedaan Organon Pharma Indonesia Tbk. dan Cerestar Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Cerestar Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 1,43 T, volume 24 jam 22,3 rb). Perbedaan utamanya: Cerestar Indonesia Tbk. jauh lebih besar — sekitar 13,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRGU | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,43 T |
Volume | — | 22,3 rb |
Lot | — | 223 |
Perputaran | — | 3,91 jt |
Harga Rata-rata | — | 175,23 |
Nilai Transaksi | — | 3,91 jt |
Harga Ekuilibrium Indikatif | — | 183 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Cerestar Indonesia Tbk (the Company) was established based on Notarial Deed No. 2 datedAugust 30, 2020 of Dwi Yulianti, S.H., notary in Jakarta The Company started its commercial operations in 2021.
Selengkapnya di halaman TRGU →